SNRI stands for serotonin-norepinephrine reuptake Inhibitor. These may also be called selective serotonin-norepinephrine reuptake Inhibitors (SSNRIs). SNRIs increase levels of serotonin and norepinephrine in the brain by blocking or delaying their reuptake by nerves.
Serotonin is a neurotransmitter that is often referred to as the “feel good hormone”. It carries messages between brain cells and contributes to well-being, good mood, appetite, social behavior, as well as helping to regulate the body’s sleep-wake cycle and internal clock.
Norepinephrine is another neurotransmitter that is also thought to be important in the regulation of emotions and thought processes. It works closely with dopamine and serotonin systems and is thought to help mobilize the brain for action, increasing alertness, focus and the retrieval of memory.
Having more serotonin and norepinephrine available in the nerve synapse means that information can be transmitted easier from one nerve to another. All SNRIs are thought to work in this way.
SNRIs help to relieve the symptoms of depression in major depressive disorder (MDD) such as low mood, irritability, feelings of worthlessness, restlessness, anxiety, and difficulty in sleeping.
In addition to depression, some SNRIs may be used to treat other conditions, such as:
Some reduction in symptoms may be noticed within one to two weeks; however, it may take six to eight weeks of treatment before the full effects are seen.
Although all SNRI antidepressants are thought to act in the same way, each has a different effect on reuptake inhibition. Venlafaxine inhibits serotonin reuptake more than norepinephrine reuptake. Although the difference is less with duloxetine and desvenlafaxine, the effect on serotonin remains greater with these two SNRIs. Milnacipran exerts a relatively equal influence on serotonin and norepinephrine whereas levomilnacipran affects norepinephrine more than serotonin. Depending on the SNRI, serotonin side effects may be seen before norepinephrine side effects.
Venlafaxine was the first SNRI marketed in the United States. Only venlafaxine immediate release and milnacipran are dosed twice a day, all the rest are dose once a day. Both venlafaxine and duloxetine are available in generic formulations.
Duloxetine has the most approved indications followed by venlafaxine. Desvenlafaxine (depression), levomilnacipran (depression) and milnacipran (fibromyalgia) have only one indication each.
Compared to other antidepressants, such as SSRIs or TCADs the SNRIs have relatively short half-lives and only venlafaxine has an active metabolite (desvenlafaxine).
Venlafaxine and duloxetine are more likely than other SNRIs to interact.
Generic name | Brand name examples |
---|---|
desvenlafaxine | Khedezla, Pristiq |
duloxetine | Cymbalta, Irenka |
levomilnacipran | Fetzima |
milnacipran | Savella |
venlafaxine | Effexor, Effexor XR |
When taken at the recommended dosage, SNRI antidepressants are considered safe. However, they have been associated with a few serious, potentially fatal, severe side effects such as:
Some of the more commonly reported side effects of SNRIs include:
Some SNRIs have been associated with a discontinuation syndrome when they have been stopped suddenly. For this reason, it is best to withdraw all antidepressants slowly.
For a complete list of side effects, please refer to the individual drug monographs.
Additional references:
Sansone RA, Sansone LA. Serotonin Norepinephrine Reuptake Inhibitors: A Pharmacological Comparison. Innovations in Clinical Neuroscience. 2014;11(3-4):37-42.
Name | Updated |
---|---|
Levomilnacipran (Levomilnacipran [ lee-voe-mil-na-si-pran ]) | 17-Aug-2023 |
Milnacipran (Milnacipran [ mil-na-si-pran ]) | 13-Aug-2023 |
Venlafaxine (Venlafaxine [ ven-la-fax-een ]) | 12-Aug-2023 |
Savella (Milnacipran [ mil-na-si-pran ]) | 14-Jul-2023 |
Irenka (Duloxetine [ du-lox-e-teen ]) | 13-Jul-2023 |
Drizalma sprinkle (Duloxetine [ du-lox-e-teen ]) | 13-Jul-2023 |
Pristiq (Desvenlafaxine [ des-ven-la-fax-een ]) | 11-Jul-2023 |
Fetzima (Levomilnacipran [ lee-voe-mil-na-si-pran ]) | 10-Jul-2023 |
Effexor (Venlafaxine [ ven-la-fax-een ]) | 10-Jul-2023 |
Duloxetine (Duloxetine [ du-lox-e-teen ]) | 10-Jul-2023 |
Desvenlafaxine (Desvenlafaxine [ des-ven-la-fax-een ]) | 10-Jul-2023 |
Cymbalta (Duloxetine [ du-lox-e-teen ]) | 10-Jul-2023 |